Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Post Opening Stability and Safe Use of Paediatric Medicines and Nutritional Preparations in India: An Evidence Based Review

Breadcrumb

  • Home
  • Post Opening Stability and Safe Use of Paediatric Medicines and Nutritional Preparations in India: An Evidence Based Review

Venugopal Reddy Iragamreddy *

Deapartment of Pediatrics, Ovum Woman and Child Speciality Hospital, Bangalore, India.

Review Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 108-112

Article DOI: 10.30574/wjbphs.2025.23.3.0809

DOI url: https://doi.org/10.30574/wjbphs.2025.23.3.0809

Received on 27 July 2025; revised on 02 September 2025; accepted on 04 September 2025

Background: In paediatric medicine, liquid preparations such as syrups, suspensions, drops, reconstituted antibiotics, anticonvulsants, endocrine therapies, and nutritional supplements are widely prescribed in India. While expiry dates are printed on packaging, they reflect unopened shelf-life and not the actual safe-use period once a product has been opened or reconstituted. Caregivers in India often continue using opened medicines until the bottle is “finished,” leading to reduced efficacy, antimicrobial resistance, and avoidable adverse outcomes.
Methods: This narrative review synthesises evidence from manufacturer product information leaflets of Indian brands, guidance from the Indian Academy of Pediatrics (IAP), the United States Pharmacopeia (USP), the World Health Organization (WHO), Ministry of AYUSH, and published literature. Medicines reviewed include antipyretics, analgesics, antiemetics, antispasmodics, antibiotics, probiotics, multivitamins, anticonvulsants, endocrine agents, Ayurvedic syrups, and paediatric nutritional preparations such as infant formula, expressed breast milk, and ready-to-use therapeutic foods (RUTF).
Results: Evidence indicates that oral suspensions such as paracetamol and ibuprofen are safe for 3–6 months after opening; reconstituted antibiotics must be discarded within 7–14 days; oral rehydration solution (ORS) should be used within 24 h; probiotics vary, with sachets consumed immediately and drops within 3 months; iron syrups last 1–3 months; multivitamins 3–6 months; vitamin D drops up to 12 months; anticonvulsants like sodium valproate and levetiracetam remain stable for 6–7 months, while phenobarbitone and carbamazepine suspensions should be discarded in 3 months; endocrinological drugs such as thyroxine drops remain usable for 6–8 weeks, insulin and growth hormone vials/pens for 28 days; infant formula tins must be used within 3–4 weeks of opening, while reconstituted feeds last only 2 h. Ayurvedic syrups lack stability data but should be discarded within 3 months.
Conclusion: In India’s hot and humid climate, conservative discard timelines are essential. Adopting standardised rules—ORS 24 h, antibiotics 7–14 d, paracetamol/ibuprofen syrups 3–6 mo, insulin and growth hormone 28 d, infant formula tins 3–4 weeks, and Ayurvedic syrups 3 mo—will prevent therapeutic failure and enhance child safety. Paediatricians should counsel families actively and advocate inclusion of Ayurvedic and nutritional preparations in safety discussions.
 

Paediatrics; Beyond-Use Date; Oral Suspensions; Anticonvulsants; Endocrine Medicines; Infant Formula; India

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0809.pdf

Preview Article PDF

Venugopal Reddy Iragamreddy. Post Opening Stability and Safe Use of Paediatric Medicines and Nutritional Preparations in India: An Evidence Based Review. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 108–112. Article DOI: https://doi.org/10.30574/wjbphs.2025.23.3.0809.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution